S5940 A Rare Case of Budd-Chiari Syndrome Secondary to Portal Vein Thrombosis Requiring Direct Intrahepatic Portosystemic Shunt (DIPS) for Refractory Ascites

Introduction: Budd-Chiari syndrome (BCS) is defined as hepatic venous outflow obstruction, regardless of the underlying mechanism. It is commonly caused by hepatic vein thrombosis and associated to prothrombotic conditions. It has an incidence of 0.5–2 cases per million in Western countries. BCS in the setting of extensive portal vein thrombosis is exceedingly rare. Management consists of a step-up approach starting with anticoagulation, and may escalate to transjugular intrahepatic portosystemic shunt (TIPS) in severe cases. Case Description/Methods: A 47-year-old woman with hypertension, decompensated cirrhosis, and uncontrolled polycythemia vera presented with abdominal pain, nausea, and shortness of breath. Physical exam remarkable for somnolence, crackles, abdominal distension with fluid wave, and bilateral lower extremity edema. Labs showed leukocytosis (WBC 32), thrombocytosis (PLT 838), hyponatremia (Na 131), elevated blood urea nitrogen (29), Cr (1.13) and hyperammonemia (120). Liver enzymes were near normal (aspartate aminotransferase 27, alanine aminotransferase 14) with elevated alkaline phosphatase (185) and hyperbilirubinemia (3.5). PT (20) international normalized ratio (1.7). Large-volume paracentesis showed SAAG >1.1. Abdominal computed tomography scan revealed ascites, hepatomegaly with mottled appearance, caudate lobe enlargement, and diminutive inferior vena cava (IVC), suggesting BCS. Also noted were splenomegaly, collateral formations, and a 9 mm non-occlusive portal vein thrombus. The patient was treated initially with diuretics and anticoagulation without clinical improvement. Interventional radiology was consulted for TIPS, however the extensive portal vein thrombosis made it complicated. The patient underwent direct intrahepatic portosystemic shunt (DIPS) with a pre-procedure hepatic venous pressure gradient of 38 mmHg and 8 mmHg post-procedure. Discussion: This case highlights poorly controlled polycythemia vera as a major risk factor for extensive splanchnic venous thrombosis leading to BCS. In this patient, financial barriers to accessing appropriate anticoagulation contributed significantly to disease progression and decompensation. When medical therapy fails, a multidisciplinary approach is warranted, often involving TIPS. This procedure creates a bypass between the portal and hepatic veins via the transjugular route. However, when hepatic vein access is not feasible, DIPS offers an alternative by connecting the portal vein directly to the inferior vena cava through the liver parenchyma. DIPS is a viable option for portal decompression and symptom relief in select patients with advanced disease.

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001151220.34275.83
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S5940 A Rare Case of Budd-Chiari Syndrome Secondary to Portal Vein Thrombosis Requiring Direct Intrahepatic Portosystemic Shunt (DIPS) for Refractory Ascites

The American Journal of Gastroenterology
Liver Disease and Transplantation
article

S5940 A Rare Case of Budd-Chiari Syndrome Secondary to Portal Vein Thrombosis Requiring Direct Intrahepatic Portosystemic Shunt (DIPS) for Refractory Ascites

article en

Abstract

Introduction: Budd-Chiari syndrome (BCS) is defined as hepatic venous outflow obstruction, regardless of the underlying mechanism. It is commonly caused by hepatic vein thrombosis and associated to prothrombotic conditions. It has an incidence of 0.5–2 cases per million in Western countries. BCS in the setting of extensive portal vein thrombosis is exceedingly rare. Management consists of a step-up approach starting with anticoagulation, and may escalate to transjugular intrahepatic portosystemic shunt (TIPS) in severe cases. Case Description/Methods: A 47-year-old woman with hypertension, decompensated cirrhosis, and uncontrolled polycythemia vera presented with abdominal pain, nausea, and shortness of breath. Physical exam remarkable for somnolence, crackles, abdominal distension with fluid wave, and bilateral lower extremity edema. Labs showed leukocytosis (WBC 32), thrombocytosis (PLT 838), hyponatremia (Na 131), elevated blood urea nitrogen (29), Cr (1.13) and hyperammonemia (120). Liver enzymes were near normal (aspartate aminotransferase 27, alanine aminotransferase 14) with elevated alkaline phosphatase (185) and hyperbilirubinemia (3.5). PT (20) international normalized ratio (1.7). Large-volume paracentesis showed SAAG >1.1. Abdominal computed tomography scan revealed ascites, hepatomegaly with mottled appearance, caudate lobe enlargement, and diminutive inferior vena cava (IVC), suggesting BCS. Also noted were splenomegaly, collateral formations, and a 9 mm non-occlusive portal vein thrombus. The patient was treated initially with diuretics and anticoagulation without clinical improvement. Interventional radiology was consulted for TIPS, however the extensive portal vein thrombosis made it complicated. The patient underwent direct intrahepatic portosystemic shunt (DIPS) with a pre-procedure hepatic venous pressure gradient of 38 mmHg and 8 mmHg post-procedure. Discussion: This case highlights poorly controlled polycythemia vera as a major risk factor for extensive splanchnic venous thrombosis leading to BCS. In this patient, financial barriers to accessing appropriate anticoagulation contributed significantly to disease progression and decompensation. When medical therapy fails, a multidisciplinary approach is warranted, often involving TIPS. This procedure creates a bypass between the portal and hepatic veins via the transjugular route. However, when hepatic vein access is not feasible, DIPS offers an alternative by connecting the portal vein directly to the inferior vena cava through the liver parenchyma. DIPS is a viable option for portal decompression and symptom relief in select patients with advanced disease.

The American Journal of GastroenterologyVol. 120(10S2)
Partnerships for the goals
Openalex Percentile: Top 33%
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.